The rating affirmation is based on several factors, including HSC’s improved operations in fiscal year 2016 and its market niche as a long-term acute care hospital for chronic diseases and rehabilitation.
After affirming the rating, S&P subsequently withdrew its underlying rating on HSC’s series 2007C bonds per HSC management’s request.
The outlook is stable, reflecting S&P’s view that HSC’s niche services provide it with a healthy enterprise profile.
More articles on healthcare finance:
CFO roundtable: 3 finance leaders on clinical staffing, retention issues
OIG audit identifies $359M in unneeded Medicare spending on chiropractic care for 2013
Full-page ad bashes CHS-owned hospital over billing, quality
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
